Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SamanTree Medical

Explore full profile

Developing a medical device to acquire tissue images during surgical cancer intervention

Lausanne, SwitzerlandFounded 2010Health Tech & Medtech
Valuation $25–50M Last recorded · 2025
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SamanTree Medical and the history behind them.

About SamanTree Medical

Samantree Medical is a startup that has developed a revolutionary device, the Histolog® Scanner, aimed at improving the efficiency and accuracy of cancer diagnosis. The company operates in the healthcare sector, specifically in the field of oncology and pathology. Its primary clients are healthcare professionals, including clinicians and pathologists.

The business model of Samantree Medical revolves around the sale and use of the Histolog® Scanner. This device uses confocal microscopy, a technique that allows for detailed imaging of the surface of excised human tissue specimens. The scanner provides high-resolution images in less than a minute, aiding in the quick detection of cancer cells. This immediate availability of results supports decision-making at the point of care, which is crucial in cancer treatment.

In addition to the scanner, Samantree Medical offers the Histolog Digital Solution, a platform for easy storing and sharing of images. This feature allows healthcare professionals to work remotely and collaborate with fellow doctors or pathologists.

The company also offers a product called the Histolog Dip and Dish, which is used to prepare the tissue specimen for scanning. The preparation process is simple and quick, taking only 10 seconds to dip the fresh tissue in a fluorescent dye and rinse it before scanning.

In summary, Samantree Medical is a healthcare startup that provides innovative solutions for quick and accurate cancer diagnosis. Its products are designed to integrate seamlessly into clinical routines, making them practical and user-friendly for healthcare professionals.

Source: Dealroom company data

At a glance

Founded
2010
Headquarters
Lausanne, Switzerland
Sector
Health Tech & Medtech

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council

Series A10 investors entered at this stage

  • Panakès Partners
  • b2venture
  • BOM - Brabant Regional Development Agency
  • Relyens
  • Wille Finance
  • Mutuelles Impact
  • XAnge
  • Noshaq
  • WE Venture
  • Karista

Series B and later2 investors entered at this stage

  • Fondation FIT
  • European Investment Bank
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇧🇪 Belgium30.2%
🇫🇷 France3.8%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SamanTree Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SamanTree Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.